Study for efficacy and safety of intravitreal injection of bevacizumab (Avastin)
Not Applicable
- Conditions
- diabetic retinopathy central retinal vein occulusion, neovascular glaucoma
- Registration Number
- JPRN-UMIN000012248
- Lead Sponsor
- ational Center for Global Health and Medicine, Kohnodai Hospital
- Brief Summary
Intravitreal injection of bevacizumab (avastin) has performed for five patients with retinal disease. All of five cases showed thinning of the retinal thickness. Neither general or local adverse events was found.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
history of ontraocular operation within one month ocular infection ocular inflammation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method fundus findings
- Secondary Outcome Measures
Name Time Method